Skip to main content

An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Nephrology

Awarded By

Sanofi US

Start Date

November 19, 2018

End Date

December 31, 2022
 

Administered By

Pediatrics, Nephrology

Awarded By

Sanofi US

Start Date

November 19, 2018

End Date

December 31, 2022